Status:
UNKNOWN
EMDR for Depressed People With Multiple Sclerosis
Lead Sponsor:
Fondazione Don Carlo Gnocchi Onlus
Collaborating Sponsors:
EMDR Europe
Catholic University of the Sacred Heart
Conditions:
Multiple Sclerosis
Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Several studies have reported high rates of depression in people with MS. Depressive symptoms represent a serious threat to quality of life and well-being. Furthermore, findings from the literature su...
Eligibility Criteria
Inclusion
- Diagnosis of relapsing-remitting or progressive MS.
- Presence of depressive symptomatology, with HADS scores \> 8, confirmed by HDRS scores (clinical interview) \> 14.
- No change of pharmacological treatment in the 3 months before the enrolment.
- Ability to communicate and to understand tasks.
- No clinical relapses or use of steroid treatment during the 4 weeks before the enrolment.
- Provided informed consent for study participation.
Exclusion
- Severe co-morbidity that would reduce life expectancy to less than one year (i.e. end-stage oncological diseases or severe cardiac dysfunction).
- Severe neuropsychological impairment evaluated with the MMSE.
- Psychosis or dissociative disorders.
- No current psychotherapy treatment
- Pregnancy.
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04875832
Start Date
May 1 2021
End Date
November 1 2022
Last Update
May 6 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.